查詢結果分析
相關文獻
- Intravenous Methylprednisolone in Treatment of Traumatic Optic Neuropathy
- 靜脈注射常見的問題與處理
- 靜脈注射乙醇導致急性中毒之病例報告
- 三度空間電腦斷層靜脈注射肝膽道膽囊攝影
- 靜脈注射輸送液配伍性之探討
- 臺北縣靜脈注射毒癮者用藥行為及心理衛生狀況初探
- 周邊靜脈注射感染之預防與護理
- Absorption and Disposition Kinetics of Trimethoprim Following Intramuscular Injection in Rabbits
- 腎動脈狹窄之靜脈注射數位化贅影消減血管攝影術
- In-Situ Transection of the Totally Implanted Venous Access System: A Case Report
頁籤選單縮合
題 名 | Intravenous Methylprednisolone in Treatment of Traumatic Optic Neuropathy=以經靜脈注射Methylprednisolone治療創傷性視神經病變之經驗 |
---|---|
作 者 | 陳幸宜; 蔡榮坤; 王惠珠; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷 期 | 14:9 1998.09[民87.09] |
頁 次 | 頁577-583 |
分類號 | 416.73 |
關鍵詞 | 創傷性視神經病變; 靜脈注射; Traumatic optic neuropathy; Methylprednisolone; |
語 文 | 英文(English) |
中文摘要 | 創傷性視神經病變是一種真正的眼科急症,而對於這個病變的處理並沒有確定有效 的治療方式。在本篇我們提出了30位創傷性視神經病變的病例,這些都是在1994年四月至 1997年三月間因頭部或眼部的外傷之後有立即性的視力喪失而來到高雄醫學院。我們回溯性 地分析病人治療的方式,受傷至接受治療的時間,視力改善的情形,及電腦斷層影像學檢查。 在這些病例當中有21位接受靜脈注射methylprednisolone治療,有2個病例接受口服的 prednisolone,有2個病例在接受靜脈注射methylprednisolone治療之後再接受視神經管減 壓手術,有5個病例並沒有接受任何治療。在這21位接受靜脈注射methylprednisolone治療 的病例當中有13位視力獲得改善(62%)。而病人一開始有光感的視力改善情形比無光感者的 視力改善情形比較好。(85%,20%)(P<0.05)此外在這30位病例中有13位有眼窩骨折(53.3%), 而病人有2位有視神經管骨折(6.7%)。這2個病例的視力並沒有獲得改善。我們的結論是, 靜脈注射methylprednisolone治療創傷性視神經病變的確有幫助,而病人一開始視力有無光 感對預後是一個重要的因子.在本篇我們亦比較我們的結果與其它的學者的研究,並且討論靜 脈注射methylprednisolone治療創傷性視神經病變的價值,並且了解到將來必須有更多前瞻 性的研究,對這個病再進一步作了解。 |
英文摘要 | Traumatic optic neuropathy is one of true ophthalmic emergencies and there is no proven form of treatment for traumatic optic neuropathy. Here we were presented with 30 cases of sudden visual loss following blunt eye trauma seen in Kaohsiung Medical College Hospital, Taiwan from April 1994 to March 1997. We analyze the treatment style, visual acuity, elapsed time since injury and orbit computed tomography retrospectively. Among them, 21 cases received intravenous methylprednisolone treatment, 2 cases received oral prednisolone, 2 cases underwent optic canal decompression in addition to intravenous methylprednisolone and 5 cases were carefully monitored without any kind of treatment. Thirteen of the 21 cases (62%) in intravenous methylprednisolone group got visual improvement. Patients with initial vision better than light perception benefitted more from treatment than did the patients who with no light perception in medical treatment group (85% VS 20 %) (p<0.05). Thirteen of the 30 cases (53.3 %) had orbit fracture and 2 of the 30 cases (6.7 %) had a fracture of the optic canal. These two cases also received optic canal decompression surgery in addition to intravenous steroid treatment but the prognosis was poor. In conclusion, intravenous methylprednisolone does offer help in traumatic optic neuropathy. Whether or not initial visual acuity was better than light perception was a key risk factor in the outcome. In this article, we also compare our results with other series in the literature and found that the value of different treatment in traumatic optic neuropathy still needs to be prospectively judged in the future. |
本系統中英文摘要資訊取自各篇刊載內容。